Plain-English translation of NCT07070076 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different ways to treat advanced liver cancer in people who might be candidates for surgery. One approach uses Yttrium-90, a radioactive treatment delivered directly to the liver tumor through blood vessels. The other uses chemotherapy drugs delivered the same way. Researchers want to know which treatment works better at stopping cancer from growing back and which one causes fewer side effects.
Advanced liver cancer is hard to treat, and doctors need better options for patients who might benefit from surgery. This trial compares two promising treatments to see which one gives patients the best chance of stopping their cancer from spreading while keeping them as safe as possible.
You likely qualify if…
You likely don't qualify if…
You will be assigned to receive one of the two treatments: either the radioactive Yttrium-90 therapy or chemotherapy through a catheter placed in your liver's blood vessel. The treatment team will do imaging and planning before your procedure. After your treatment, you'll have follow-up visits at 1, 3, and 6 months, where doctors will check how well the treatment worked, monitor for side effects, and track your symptoms.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China